SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19214951
Source:
http://linkedlifedata.com/resource/pubmed/id/19214951
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005682
,
umls-concept:C0031740
,
umls-concept:C0085957
,
umls-concept:C0205210
,
umls-concept:C0205281
,
umls-concept:C0282461
pubmed:issue
2
pubmed:dateCreated
2009-3-19
pubmed:abstractText
This multicentre phase III study was designed to compare the efficacy of Bacillus Calmette Guérin (BCG) instillations and photodynamic therapy (PDT) in the treatment of patients with intermediate and high-risk nonmuscle invasive bladder cancer.
pubmed:language
ger
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0421406
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/BCG Vaccine
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1438-8820
pubmed:author
pubmed-author:BöhleAA
,
pubmed-author:BüttnerHH
,
pubmed-author:DoehnCC
,
pubmed-author:JochamDD
,
pubmed-author:KauschII
,
pubmed-author:PflügerHH
,
pubmed-author:SteinerHH
,
pubmed-author:von WietersheimJJ
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
91-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19214951-Administration, Intravesical
,
pubmed-meshheading:19214951-Adult
,
pubmed-meshheading:19214951-Aged
,
pubmed-meshheading:19214951-BCG Vaccine
,
pubmed-meshheading:19214951-Carcinoma, Papillary
,
pubmed-meshheading:19214951-Carcinoma in Situ
,
pubmed-meshheading:19214951-Chemotherapy, Adjuvant
,
pubmed-meshheading:19214951-Combined Modality Therapy
,
pubmed-meshheading:19214951-Cystoscopy
,
pubmed-meshheading:19214951-Disease Progression
,
pubmed-meshheading:19214951-Disease-Free Survival
,
pubmed-meshheading:19214951-Female
,
pubmed-meshheading:19214951-Follow-Up Studies
,
pubmed-meshheading:19214951-Hematoporphyrin Photoradiation
,
pubmed-meshheading:19214951-Humans
,
pubmed-meshheading:19214951-Kaplan-Meier Estimate
,
pubmed-meshheading:19214951-Male
,
pubmed-meshheading:19214951-Middle Aged
,
pubmed-meshheading:19214951-Neoplasm Recurrence, Local
,
pubmed-meshheading:19214951-Neoplasm Staging
,
pubmed-meshheading:19214951-Quality of Life
,
pubmed-meshheading:19214951-Urinary Bladder Neoplasms
pubmed:year
2009
pubmed:articleTitle
[BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
pubmed:affiliation
Die Institutsangaben sind am Ende des Beitrags gelistet. Prof.Jocham.MUL@t-online.de
pubmed:publicationType
Journal Article
,
Comparative Study
,
English Abstract
,
Randomized Controlled Trial
,
Multicenter Study
,
Clinical Trial, Phase III